Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
Eligible age
18–45 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs is unclear but may be related to impaired endothelial function and dysregulation of the angiotensin system that occurs during the preeclamptic pregnancy and persists postpartum, despite the remission of clinical symptoms. The purpose of this investigation is to determine the mechanisms contributing to this lasting blood vessel damage caused by reduced endothelial function in women who have had preeclampsia compared to women who had a healthy pregnancy. Identification of these mechanisms and treatment strategies may lead to better clinical management of cardiovascular disease risk in these women. The purpose of this study is to examine the microvascular differences in women who have had preeclampsia following activation of protective angiotensin receptors in the skin. This will help increase understanding of the mechanisms of angiotensin II receptors in these women, and how activation of these receptors may restore microvascular function. In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) the investigators examine the blood vessels in a dime-sized area of the skin.
Sponsor: Anna Stanhewicz, PhD
You may qualify if…
- ✓ women who had preeclampsia and women who did not have preeclampsia
- ✓ 12 weeks to 5 years postpartum
- ✓ 18-45 years old
You may not qualify if…
- ✕ history of hypertension or metabolic disease before pregnancy
- ✕ history of gestational diabetes
- ✕ skin diseases
- ✕ current tobacco use
- ✕ current antihypertensive medication
- ✕ statin or other cholesterol-lowering medication
- ✕ currently pregnant or planning to become pregnant
- ✕ body mass index less than 18.5 kg/m2
Where it's recruiting
Iowa City
Source: ClinicalTrials.gov · NCT05937841 · last updated 2025-08-24